A newer, more effective treatment for uterine fibroids is available that doesn't require surgery.

That's good news for the estimated 26 million women in the U.S. who have fibroids — including the millions of Black women who are disproportionately affected by these benign tumors. Black women in the U.S. are up to three times more likely to develop fibroids than white women.

Dr. Elizabeth Stewart, Mayo gynecologist and researcher recently published a review on these approved fibroid medications. They are called oral gonadotropin-releasing hormone (GnRH) antagonist combinations.
____________________________________________
FOR THE PUBLIC: More health and medical news on the Mayo Clinic News Network. [ Ссылка ]

FOR THE MEDIA ONLY: Register at [ Ссылка ]... to access clean and nat sound versions of this video on the Mayo Clinic News Network. [ Ссылка ]

Mayo Clinic [ Ссылка ] Follow Mayo Clinic on Instagram: [ Ссылка ] Like Mayo Clinic on Facebook: [ Ссылка ] Follow Mayo Clinic on Twitter: [ Ссылка ]

свернуть